Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Strides Pharma Science: Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.
News Announcement

Strides Pharma Science: Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.

10-Aug-2022 Follow Value Research Online on Google download pdfDownload PDF Strides Pharma

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on August 09 2022 for S Vimalkumar

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.